Trius Therapeutics (TSRX)
Create an Alert
8.63
+0.03 +0.35%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Trius Therapeutics Return on Equity:
-88.31% for Dec. 31, 2012Trius Therapeutics Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -88.31% |
| Dec. 31, 2012 | -79.84% |
| Sept. 30, 2012 | -76.26% |
| June 30, 2012 | -30.89% |
| March 31, 2012 | -27.70% |
| Dec. 31, 2011 | -38.17% |
| Sept. 30, 2011 | -29.84% |
| June 30, 2011 | -150.7% |
| March 31, 2011 | -158.7% |
| Dec. 31, 2010 | -2025% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
TSRX Return on Equity Benchmarks
| Companies | |
|---|---|
| Rosetta Genomics | |
| Chembio Diagnostics | 7.10% |
| Alliance HealthCare Services |
TSRX Return on Equity Rankings
| Overall |
60th percentile 6552 of 16770 |
| Sector |
61st percentile 538 of 1408 in Healthcare |
| Industry |
63rd percentile 47 of 130 in Diagnostics & Research |
TSRX Return on Equity Range, Past 5 Years
| Minimum | -2025% | Dec 2010 |
| Maximum | -27.70% | Mar 2012 |
| Average | -270.5% |
